关于癌症药物耐药性的AEG-1:从分子洞察到治疗挑战
Wali Ullah1, Hail Kim2, Sanghee Han2
1Department of Zoology, Islamia College University, Peshawar, Pakistan.
Advances in cancer research
|November 16, 2025
概括
星细胞升高基因-1 (AEG-1) 通过影响关键信号通路,驱动癌症的进展和耐药性. 准AEG-1为开发下一代癌症疗法提供了一个有前途的战略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 天体细胞升高基因-1 (AEG-1),也称为甲素 (MTDH),是一种多功能瘤基因.
- AEG-1与癌症的进展,转移,免疫逃避和耐药性有关.
- 它调节PI3K/Akt,NF-κB和Wnt/β-catenin等关键信号通路.
研究的目的:
- 为各种癌症提供AEG-1-介导药物耐药性机制的全面概述.
- 检查瘤特异性信号背景和塑造AEG-1功能的免疫微环境相互作用.
- 讨论治疗挑战和针对AEG-1的新兴策略.
主要方法:
- 对AEG-1功能及其在癌症中的作用的现有文献的综述.
- 对AEG-1与分子伙伴 (SND1,USP10,核素) 的相互作用进行分析.
- 探索治疗策略,包括RNA干扰,植物化学物质和纳米粒子.
主要成果:
- AEG-1促进表皮细胞-介质细胞过渡,抑制细胞亡,增强癌症干性,并赋予多种药物耐药性.
- 它的致癌潜力通过与合作伙伴的相互作用得到放大,有助于免疫抑制和治疗耐药性.
- AEG-1是一种具有翻译相关性的预后和预测生物标志物.
结论:
- AEG-1是各种恶性瘤中药物耐药性的中心调解者.
- 准AEG-1为下一代癌症疗法提供了一个引人注目的战略.
- 未来的研究应该集中在生物标志物指导的临床试验和开发瘤特异性的AEG-1抑制剂上.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
